Osteoarthritis Knee Pain Relief Study of 0.25% 920-CGS-200

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Osteoarthritis, Knee
Interventions
DRUG

Capsaicin Topical Solution

Over-the-counter Tentative Final Monograph compliant product with 0.25% capsaicin

OTHER

Drug product vehicle

This is the vehicle for the active treatment drug product, but without capsaicin

Trial Locations (3)

Unknown

Research Center, Clearwater

Research Center, Tampa

Research Center, Dallas

Sponsors
All Listed Sponsors
collaborator

Palm Beach Research, Inc

UNKNOWN

lead

Propella Therapeutics

INDUSTRY

NCT03124407 - Osteoarthritis Knee Pain Relief Study of 0.25% 920-CGS-200 | Biotech Hunter | Biotech Hunter